Phytochemicals as future drugs for Parkinson’s disease: a comprehensive review

References

Agim, Z.S., and Cannon, J.R. (2015). Dietary factors in the etiology of Parkinson’s disease. BioMed. Res. Int. 2015, Article ID 672838, 16 pages.10.1155/2015/672838Search in Google Scholar PubMed PubMed Central

Anandhan, A., Tamilselvam, K., Radhiga, T., Rao, S., Essa, M.M., and Manivasagam T. (2012). Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson’s disease. Brain Res. 1433, 104–113.10.1016/j.brainres.2011.11.021Search in Google Scholar PubMed

Anderson, W., Barrows, M., Lopez, F., Rogers, S., Ortiz-Coffie, A., Norman, D., Hodges, J., McDonald, K., Barnes, D., McCall, S., et al. (2012). Investigation of the anxiolytic effects of naringenin, a component of Mentha aquatica, in the male Sprague-Dawley rat. Holist. Nurs. Pract. 26, 52–57.10.1097/HNP.0b013e31823c003aSearch in Google Scholar PubMed

Ang-Lee, M.K., Moss, J., and Yuan, C.S. (2001). Herbal medicines and perioperative care. J. Am. Med. Assoc. 286, 208–216.10.1001/jama.286.2.208Search in Google Scholar PubMed

Ardah, M.T., Paleologou, K.E., Lv, G., Menon, S.A., Abul Khair, S.B., Lu, J.H., Safieh-Garabedian, B., Al-Hayani, A.A., Eliezer, D., Li, M., et al. (2015). Ginsenoside Rb1 inhibits fibrillation and toxicity of α-synuclein and disaggregates preformed fibrils. Neurobiol. Dis. 74, 89–101.10.1016/j.nbd.2014.11.007Search in Google Scholar PubMed PubMed Central

Bahramsoltani, R., Farzaei, M.H., Farahani, M.S., and Rahimi, R. (2015). Phytochemical constituents as future antidepressants: a comprehensive review. Rev. Neurosci. 26, 699–719.10.1515/revneuro-2015-0009Search in Google Scholar PubMed

Barbosa-Filho, J.M., Piuvezam, M.R., Moura, M.D., Silva, M.S., Lima, K.V.B., da-Cunha, E.V.L., Fechine, I.M., and Takemura, O.S. (2006). Anti-inflammatory activity of alkaloids: a twenty-century review. Braz. J. Pharmacogn. 16, 109–139.10.1590/S0102-695X2006000100020Search in Google Scholar

Basheer, L., and Kerem, Z. (2015). Interactions between CYP3A4 and dietary polyphenols. Oxid. Med. Cell. Longev. 2015, Article ID 854015, 15 pages.10.1155/2015/854015Search in Google Scholar PubMed PubMed Central

Bassani, T.B., Vital, M.A., and Rauh, L.K. (2015). Neuroinflammation in the pathophysiology of Parkinson’s disease and therapeutic evidence of anti-inflammatory drugs. Arq. Neuropsiquiatr. 73, 616–623.10.1590/0004-282X20150057Search in Google Scholar PubMed

Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., and Jackson-Lewis, V.R. (2015). Oxidative stress and Parkinson’s disease. Front. Neuroanat. 9, 91.10.3389/fnana.2015.00091Search in Google Scholar PubMed PubMed Central

Brandenburg, L.O., Kipp, M., Lucius, R., Pufe, T., and Wruck, C.J. (2010). Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm. Res. 59, 443–450.10.1007/s00011-009-0116-5Search in Google Scholar PubMed

Chakroborty, D., Sarkar, C., Yu, H., Wang, J., Liu, Z., Dasgupta, P.S., and Basu, S. (2011). Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Krüppel-like factor-2 expression in tumor endothelial cells. Proc. Natl. Acad. Sci. USA. 108, 20730–20735.10.1073/pnas.1108696108Search in Google Scholar PubMed PubMed Central

Chao, J., Yu, M.S., Ho, Y.S., Wang, M., and Chang, R.C. (2008). Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic. Biol. Med. 45, 1019–1026.10.1016/j.freeradbiomed.2008.07.002Search in Google Scholar PubMed

Chen, J.H., Ou, H.P., Lin, C.Y., Lin, F.J., Wu, C.R., Chang, S.W., and Tsai, C.W. (2012). Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem. Res. Toxicol. 25, 1893–1901.10.1021/tx300171uSearch in Google Scholar PubMed

Cheung, Z.H., and Ip, N.Y. (2009). The emerging role of autophagy in Parkinson’s disease. Mol. Brain 2, 29.10.1186/1756-6606-2-29Search in Google Scholar PubMed PubMed Central

Choi, S.Y., Son, T.G., Park, H.R., Jang, Y.J., Oh, S.B., Jin, B., and Lee, J. (2012). Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson’s disease model. J. Neurosci. Res. 90, 1842–1849.10.1002/jnr.23061Search in Google Scholar PubMed

Cleren, C., Calingasan, N.Y., Chen, J., and Beal, M.F. (2005). Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J. Neurochem. 94, 995–1004.10.1111/j.1471-4159.2005.03253.xSearch in Google Scholar PubMed

De Sousa Falcão, H., Leite, J.A., Barbosa-Filho, J.M., de Athayde-Filho, P.F., de Oliveira Chaves, M.C., Moura, M.D., Ferreira, A.L., de Almeida, A.B.A., Souza-Brito, A.R.M., de Fátima Formiga Melo Diniz, M., et al. (2008). Gastric and duodenal antiulcer activity of alkaloids: a review. Molecules 13, 3198–3223.10.3390/molecules13123198Search in Google Scholar PubMed PubMed Central

Deng, C., Tao, R., Yu, S.Z., and Jin, H. (2012a). Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. Mol. Med. Rep. 5, 847–851.Search in Google Scholar

Deng, C., Tao, R., Yu, S.Z., and Jin, H. (2012b). Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation. Mol. Med. Rep. 6, 215–219.Search in Google Scholar

Du, T., Li, L., Song, N., Xie, J., and Jiang, H. (2010). Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells. Int. J. Toxicol. 29, 625–633.10.1177/1091581810383705Search in Google Scholar PubMed

Du, X.X., Xu, H.M., Jiang, H., Song, N., Wang, J., and Xie, J.X. (2012). Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson’s disease. Neurosci. Bull. 28, 253–258.10.1007/s12264-012-1238-2Search in Google Scholar PubMed PubMed Central

Fabio, G.D., Romanucci, V., Marco, A.D., and Zarrelli, A. (2014). Triterpenoids from Gymnema sylvestre and their pharmacological activities. Molecules 19, 10956–10981.10.3390/molecules190810956Search in Google Scholar PubMed PubMed Central

Farahani, M.S., Bahramsoltani, R., Farzaei, M.H., Abdollahi, M., and Rahimi, R. (2015). Plant-derived natural medicines for the management of depression: an overview of mechanisms of action. Rev. Neurosci. 26, 305–321.10.1515/revneuro-2014-0058Search in Google Scholar PubMed

Farzaei, M.H., Abdollahi, M., and Rahimi, R. (2015). Role of dietary polyphenols in the management of peptic ulcer. World J. Gastroenterol. 21, 6499–6517.10.3748/wjg.v21.i21.6499Search in Google Scholar PubMed PubMed Central

Farzaei, M.H., Bahramsoltani, R., Rahimi, R., Abbasabadi, F., and Abdollahi, M. (2016). A systematic review of plant-derived natural compounds for anxiety disorders. Curr. Top. Med. Chem. Epub ahead of print.Search in Google Scholar

Filomeni, G., Graziani, I., De Zio, D., Dini, L., Centonze, D., Rotilio, G., and Ciriolo, M.R. (2012). Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson’s disease. Neurobiol. Aging 33, 767–785.10.1016/j.neurobiolaging.2010.05.021Search in Google Scholar PubMed

Fu, R.H., Harn, H.J., Liu, S.P., Chen, C.S., Chang, W.L., Chen, Y.M., Huang, J.E., Li, R.J., Tsai, S.Y., Hung, H.S., et al. (2014). n-Butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson’s disease. PLoS ONE 9:e85305.10.1371/journal.pone.0085305Search in Google Scholar PubMed PubMed Central

Fujikawa, T., Kanada, N., Shimada, A., Ogata, M., Suzuki, I., Hayashi, I., and Nakashima, K. (2005). Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced parkinsonian rats. Biol. Pharm. Bull. 28, 169–172.10.1248/bpb.28.169Search in Google Scholar PubMed

García, C., Palomo-Garo, C., García-Arencibia, M., Ramos, J., Pertwee, R., and Fernández-Ruiz, J. (2011). Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease. Br. J. Pharmacol. 163, 1495–1506.10.1111/j.1476-5381.2011.01278.xSearch in Google Scholar PubMed PubMed Central

Geng, X., Tian, X., Tu, P., and Pu, X. (2007). Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson’s disease. Eur. J. Pharmacol. 564, 66–74.10.1016/j.ejphar.2007.01.084Search in Google Scholar PubMed

González-Burgos, E., and Gómez-Serranillos, M.P. (2012). Terpene compounds in nature: a review of their potential antioxidant activity. Curr. Med. Chem. 19, 5319–5341.10.2174/092986712803833335Search in Google Scholar PubMed

Gopalakrishna, A., and Alexander, S.A. (2015). Understanding Parkinson disease: a complex and multifaceted illness. J. Neurosci. Nurs. 47, 320–326.10.1097/JNN.0000000000000162Search in Google Scholar PubMed

Ham, A., Lee, H.J., Hong, S.S., Lee, D., and Mar, W. (2012). Moracenin D from Mori cortex radicis protects SH-SY5Y cells against dopamine-induced cell death by regulating nurr1 and α-synuclein expression. Phytother. Res. 26, 620–624.10.1002/ptr.3592Search in Google Scholar PubMed

Han, J.M., Lee, Y.J., Lee, S.Y., Kim, E.M., Moon, Y., Kim, H.W., and Hwang, O. (2007). Protective effect of sulforaphane against dopaminergic cell death. J. Pharmacol. Exp. Ther. 321, 249–256.10.1124/jpet.106.110866Search in Google Scholar PubMed

Huang, J.Z., Chen, Y.Z., Su, M., Zheng, H.F., Yang, Y.P., Chen, J., and Liu, C.F. (2010). dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson’s disease. Neurosci. Lett. 475, 89–94.10.1016/j.neulet.2010.03.053Search in Google Scholar PubMed

Ikram, N.K., Zhan, X., Pan, X.W., King, B.C., and Simonsen, H.T. (2015). Stable heterologous expression of biologically active terpenoids in green plant cells. Front. Plant Sci. 18, 129.10.3389/fpls.2015.00129Search in Google Scholar PubMed PubMed Central

Kabuto, H., Nishizawa, M., Tada, M., Higashio, C., Shishibori, T., and Kohno, M. (2005). Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem. Res. 30, 325–332.10.1007/s11064-005-2606-3Search in Google Scholar PubMed

Khadira Sereen, A., Priya, N., and Vijayalakshmi, K. (2014). Effect of sesamol and folic acid on behavioural activity and antioxidant profile of rats induced with 6-hydroxy dopamine. Int. J. Pharmacogn. Phytochem. Res. 6, 930–935.Search in Google Scholar

Kim, H.G., Ju, M.S., Ha, S.K., Lee, H., Lee, H., Kim, S.Y., and Oh M.S. (2012a). Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol. Pharm. Bull. 35, 1287–1294.10.1248/bpb.b12-00127Search in Google Scholar PubMed

Kim, K.H., Song, K., Yoon, S.H., Shehzad, O., Kim, Y.S., and Son, J.H. (2012b). Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside reactivation of nitric oxide signaling. J. Biol. Chem. 287, 44109–44120.10.1074/jbc.M112.408146Search in Google Scholar PubMed PubMed Central

Klepacka, J., Gujska, E., and Michalak, J. (2011). Phenolic compounds as cultivar- and variety-distinguishing factors in some plant products. Plant Foods Hum. Nutr. 66, 64–69.10.1007/s11130-010-0205-1Search in Google Scholar PubMed PubMed Central

Kumar, H., Kim, I.S., More, S.V., Kim, B.W., Bahk, Y.Y., and Choi, D.K. (2013). Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson’s disease model. Evid. Based Complement Alternat. Med. 2013, Article ID 514095, 13 pages.10.1155/2013/514095Search in Google Scholar PubMed PubMed Central

Lakhan, S.E., and Vieira, K.F. (2010). Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutr. J. 9, 42.10.1186/1475-2891-9-42Search in Google Scholar PubMed PubMed Central

Lastres-Becker, I., Molina-Holgado, F., Ramos, J.A., Mechoulam, R., and Fernández-Ruiz, J. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease. Neurobiol. Dis. 19, 96–107.10.1016/j.nbd.2004.11.009Search in Google Scholar PubMed

Leal, L.K.A.M., Júnior, H.N., Cunha, G.M.A., Moraes, M.O., Pessoa, C., Oliveira, R.A., Silveira, E.R., Canuto, K.M., and Viana, G.S.B. (2005). Amburoside A, a glucoside from Amburana cearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity. Neurosci. Lett. 388, 86–90.10.1016/j.neulet.2005.06.034Search in Google Scholar PubMed

Lee, Y., Park, H.R., Chun, H.J., and Lee, J. (2015). Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease via mitochondrial stabilization. J. Neurosci. Res. 93, 755–765.10.1002/jnr.23544Search in Google Scholar PubMed

Levites, Y., Weinreb, O., Maor, G., Youdim, M.B., and Mandel, S. (2001). Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 78, 1073–1082.10.1046/j.1471-4159.2001.00490.xSearch in Google Scholar PubMed

Li, S., and Pu, X.P. (2011). Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Biol. Pharm. Bull. 34, 1291–1296.10.1248/bpb.34.1291Search in Google Scholar PubMed

Li, Y.Y., Lu, J.H., Li, Q., Zhao, Y.Y., and Pu, X.P. (2008). Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP+) in primary cultures of rat mesencephalic neurons. Eur. J. Pharmacol. 579, 134–140.10.1016/j.ejphar.2007.10.052Search in Google Scholar PubMed

Li, B., Jeong, G.S., Kang, D.G., Lee, H.S., and Kim, Y.C. (2009). Cytoprotective effects of lindenenyl acetate isolated from Lindera strychnifolia on mouse hippocampal HT22 cells. Eur. J. Pharmacol. 614, 58–65.10.1016/j.ejphar.2009.04.056Search in Google Scholar PubMed

Li, B.Y., Yuan, Y.H., Hu, J.F., Zhao, Q., Zhang, D.M., and Chen, N.H. (2011). Protective effect of Bu-7, a flavonoid extracted from Clausena lansium, against rotenone injury in PC12 cells. Acta Pharmacol. Sin. 32, 1321–1326.10.1038/aps.2011.119Search in Google Scholar PubMed PubMed Central

Liang, Z., Shi, F., Wang, Y., Lu, L., Zhang, Z., Wang, X., and Wang, X. (2011). Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. Neurosci. Lett. 497, 104–109.10.1016/j.neulet.2011.04.041Search in Google Scholar PubMed

Liu, H.Q., Zhang, W.Y., Luo, X.T., Ye, Y., and Zhu, X.Z. (2006). Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease by activation of adenosine A1 receptor. Br. J. Pharmacol. 148, 314–325.10.1038/sj.bjp.0706732Search in Google Scholar PubMed PubMed Central

Mandel, S., Maor, G., and Youdim, M.B. (2004). Iron and a-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. J. Mol. Neurosci. 24, 401–416.10.1385/JMN:24:3:401Search in Google Scholar

Meng, H., Li, C., Feng, L., Cheng, B., Wu, F., Wang, X., Li, Z., and Liu, S. (2007). Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12. Int. J. Dev. Neurosci. 25, 509–514.10.1016/j.ijdevneu.2007.09.010Search in Google Scholar

Miller, R.L., James-Kracke, M., Sun, G.Y., and Sun, A.Y. (2009). Oxidative and inflammatory pathways in Parkinson’s disease. Neurochem. Res. 34, 55–65.10.1007/s11064-008-9656-2Search in Google Scholar

Moon, H.E., and Paek, S.H. (2015). Mitochondrial dysfunction in Parkinson’s disease. Exp. Neurobiol. 24, 103–116.10.5607/en.2015.24.2.103Search in Google Scholar

Morroni, F., Tarozzi, A., Sita, G., Bolondi, C., Moraga, J.M.Z., Cantelli-Forti, G., and Hrelia, P. (2013). Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson’s disease. Neurotoxicology 36, 63–71.10.1016/j.neuro.2013.03.004Search in Google Scholar

Mu, X., He, G., Cheng, Y., Li, X., Xu, B., and Du, G. (2009). Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol. Biochem. Behav. 92, 642–648.10.1016/j.pbb.2009.03.008Search in Google Scholar

Nirumand, M.C., Farzaei, M.H., and Amin, G. (2015). Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review. J. Tradit. Chin. Med. 35, 104–109.10.1016/S0254-6272(15)30016-9Search in Google Scholar

Ortiz-Ortiz, M.A., Morán, J.M., Ruiz-Mesa, L.M., Niso-Santano, M., Bravo-SanPedro, J.M., Gómez-Sánchez, R., González-Polo, R.A., and Fuentes, J.M. (2010). Curcumin exposure induces expression of the Parkinson’s disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci. Lett. 468, 120–124.10.1016/j.neulet.2009.10.081Search in Google Scholar

Paduch, R., Kandefer-Szerszeń, M., Trytek, M., and Fiedurek, J. (2007). Terpenes: substances useful in human healthcare. Arch. Immunol. Ther. Exp. 55, 315–327.10.1007/s00005-007-0039-1Search in Google Scholar

Pandey, K.B., and Rizvi, S.I. (2009). Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2, 270–278.10.4161/oxim.2.5.9498Search in Google Scholar

Park, B.C., Lee, Y.S., Park, H.J., Kwak, M.K., Yoo, B.K., Kim, J.Y., and Kim, J.A. (2007). Protective effects of fustin, a flavonoid from Rhus verniciflua Stokes, on 6-hydroxydopamine-induced neuronal cell death. Exp. Mol. Med. 39, 316–326.10.1038/emm.2007.35Search in Google Scholar PubMed

Park, J.A., Kim, S., Lee, S.Y., Kim, C.S., Kim do, K, Kim, S.J., and Chun, H.S. (2008). Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. NeuroReport 19, 1301–1304.10.1097/WNR.0b013e32830abc1fSearch in Google Scholar PubMed

Park, G., Kim, H.G., Ju, M.S., Ha, S.K., Park, Y., Kim, S.Y., and Oh, M.S. (2013). 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson’s disease models via anti-neuroinflammation. Acta Pharmacol. Sin. 34, 1131–1139.10.1038/aps.2013.57Search in Google Scholar PubMed PubMed Central

Pasban-Aliabadi, H., Esmaeili-Mahani, S., Sheibani, V., Abbasnejad, M., Mehdizadeh, A., and Yaghoobi, M.M. (2013). Inhibition of 6-hydroxydopamine-induced PC12 cell apoptosis by olive (Olea europaea L.) leaf extract is performed by its main component oleuropein. Rejuv. Res. 16, 134–142.10.1089/rej.2012.1384Search in Google Scholar PubMed

Pérez, H.J., Carrillo, S.C., García, E., Ruiz-Mar, G., Pérez-Tamayo, R., and Chavarría, A. (2014). Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson’s disease. Toxicology 319, 38–43.10.1016/j.tox.2014.02.009Search in Google Scholar PubMed

Priyadarshi, A., Khuder, S.A., Schaub, E.A., and Priyadarshi, S.S. (2001). Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ. Res. 86, 122–127.10.1006/enrs.2001.4264Search in Google Scholar PubMed

Qualls, Z., Brown, D., Ramlochansingh, C., Hurley, L.L., and Tizabi, Y. (2014). Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson’s disease. Neurotoxicol. Res. 25, 81–89.10.1007/s12640-013-9433-0Search in Google Scholar PubMed PubMed Central

Reinisalo, M., Kårlund, A., Koskela, A., Kaarniranta, K., and Karjalainen, R.O. (2015). Polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases. Oxid. Med. Cell. Longev. 2015, Article ID 340520, 24 pages.10.1155/2015/340520Search in Google Scholar PubMed PubMed Central

Rekha, K.R., Selvakumar, G.P., and Sivakamasundari, R.I. (2014). Effects of syringic acid on chronic MPTP/probenecid induced motor dysfunction, dopaminergic markers expression and neuroinflammation in C57BL/6 mice. Biomed. Aging Pathol. 4, 95–104.10.1016/j.biomag.2014.02.004Search in Google Scholar

Ren, P., Jiang, H., Li, R., Wang, J., Song, N., Xu, H.M., and Xie, J.X. (2009). Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells. J. Mol. Neurosci. 39, 220–225.10.1007/s12031-009-9182-ySearch in Google Scholar PubMed

Ryu, H.W., Oh, W.K., Jang, I.S., and Park, J. (2013). Amurensin G induces autophagy and attenuates cellular toxicities in a rotenone model of Parkinson’s disease. Biochem. Biophys. Res. Commun. 433, 121–126.10.1016/j.bbrc.2013.02.053Search in Google Scholar PubMed

Shay, J., Elbaz, H.A., Lee, I., Zielske, S.P., Malek M.H., and Hüttemann, M. (2015). Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid. Med. Cell. Longev. 2015, Article ID 181260, 13 pages.10.1155/2015/181260Search in Google Scholar PubMed PubMed Central

Shukla, V., Phulara, S.C., Yadav, D., Tiwari, S., Kaur, S., Gupta, M.M., Nazir, A., and Pandey, R. (2012). Iridoid compound 10-O-trans-p-coumaroylcatalpol extends longevity and reduces α synuclein aggregation in Caenorhabditis elegans. CNS Neurol. Disord. Drug Targets 11, 984–992.10.2174/1871527311211080007Search in Google Scholar PubMed

Singh, A., Naidu, P.S., and Kulkarni, S.K. (2003). Quercetin potentiates L-dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition. Pharmacology 68, 81–88.10.1159/000069533Search in Google Scholar PubMed

Sodagari, H.R., Farzaei, M.H., Bahramsoltani, R., Abdolghaffari, A.H., Mahmoudi, M., and Rezaei, N. (2015). Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease. Exp. Rev. Gastroenterol. Hepatol. 9, 807–820.10.1586/17474124.2015.1002086Search in Google Scholar PubMed

Stalikas, C.D. (2007). Extraction, separation, and detection methods for phenolic acids and flavonoids. J. Sep. Sci. 30, 3268–3295.10.1002/jssc.200700261Search in Google Scholar PubMed

Sun, X., Cao, Y.B., Hu, L.F., Yang, Y.P., Li, J., Wang, F., and Liu, C.F. (2011). ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation. Brain Res. 1396, 77–87.10.1016/j.brainres.2011.04.011Search in Google Scholar PubMed

Tai, K.K., and Truong, D.D. (2010). (-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells. Neurosci. Lett. 482, 183–187.10.1016/j.neulet.2010.06.018Search in Google Scholar PubMed

Tamilselvam, K., Braidy, N., Manivasagam, T., Essa, M.M., Prasad, N.R., Karthikeyan, S., Thenmozhi, A.J., Selvaraju, S., and Guillemin, G.J. (2013). Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson’s disease. Oxid. Med. Cell. Longev. 2013, Article ID 102741, 11 pages.10.1155/2013/102741Search in Google Scholar PubMed PubMed Central

Vauzour, D., Buonfiglio, M., Corona, G., Chirafisi, J., Vafeiadou, K., Angeloni, C., Hrelia, S., Hrelia, P., and Spencer, J.P. (2010). Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol. Nutr. Food Res. 54, 532–542.10.1002/mnfr.200900197Search in Google Scholar PubMed

Wang, X.J., and Xu, J.X. (2005). Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Neurosci. Res. 51, 129–138.10.1016/j.neures.2004.10.001Search in Google Scholar PubMed

Wang, Y., Xu, H., Fu, Q., Ma, R., and Xiang, J. (2011). Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats. J. Neurol. Sci. 304, 29–34.10.1016/j.jns.2011.02.025Search in Google Scholar PubMed

Wang, S., Jing, H., Yang H, Liu, Z., Guo, H., Chai, L., and Hu, L. (2015). Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson’s disease. J. Ethnopharmacol. 164, 247–255.10.1016/j.jep.2015.01.042Search in Google Scholar PubMed

Wu, C.R., Tsai, C.W., Chang, S.W., Lin, C.Y., Huang, L.C., and Tsai, C.W. (2015). Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease: involvement of antioxidative enzymes induction. Chem. Biol. Interact. 225, 40–46.10.1016/j.cbi.2014.11.011Search in Google Scholar PubMed

Xie, C.L., Gu, Y., Wang, W.W., Lu, L., Fu, D.L., Liu, A.J., Li, H.Q., Li, J.H., Lin, Y., and Tang, W.J. (2013). Efficacy and safety of Suanzaoren decoction for primary insomnia: a systematic review of randomized controlled trials. BMC Complement. Alternat. Med. 13, 18.10.1186/1472-6882-13-18Search in Google Scholar PubMed PubMed Central

Xu, C.L., Qu, R., Zhang, J., Li, L.F., and Ma, S.P. (2013). Neuroprotective effects of madecassoside in early stage of Parkinson’s disease induced by MPTP in rats. Fitoterapia 90, 112–118.10.1016/j.fitote.2013.07.009Search in Google Scholar PubMed

Ye, Q., Ye, L., Xu, X., Huang, B., Zhang, X., Zhu, Y., and Chen, X. (2012). Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway. BMC Complement. Alternat. Med. 12, 82.10.1186/1472-6882-12-82Search in Google Scholar PubMed PubMed Central

Yu, C.H., Ishii, R., Yu, S.C., and Takeda, M. (2014). Yokukansan and its ingredients as possible treatment options for schizophrenia. Neuropsychiatr. Dis Treat. 10, 1629–1634.10.2147/NDT.S67607Search in Google Scholar PubMed PubMed Central

Zhao, G., Zheng, X.W., Qin, G.W., Gai, Y., Jiang, Z.H., and Guo, L.H. (2009). In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of D3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.). Cell`. Mol. Life Sci. 66, 1617–1629.10.1007/s00018-009-9030-9Search in Google Scholar PubMed